Simulations Plus, Inc. SLP

Updated: 10 Aug 2026

NASDAQ | Technology | Drug development software

No signal published yet

We already track Simulations Plus and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Simulations Plus free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Technology
Sector
Drug development software
We're already tracking Simulations Plus, Inc. — here are the latest events we've registered

Recent News

  • In June 2026, Simulations Plus entered into a definitive agreement to be acquired by affiliates of Altaris in an all-cash transaction valued at $18.50 per share, or approximately $375 million. Subsequently in July 2026, the company reported third-quarter fiscal 2026 revenue of $21.89 million, representing a 7% increase year-over-year.

What Firelda Watch includes for Simulations Plus, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Simulations Plus, Inc. will be delivered in the same format.

Want to follow Simulations Plus, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Simulations Plus free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Simulations Plus, Inc. SLP
Simulations Plus — follow and we'll monitor it
Follow Simulations Plus free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.